Methods And Compositions Comprising At Least One Alfa3 Beta4 Nachr Antagonist Or Pharmaceutically Acceptable Salt Thereof

  • Published: Jul 31, 2008
  • Earliest Priority: Jan 26 2007
  • Family: 8
  • Cited Works: 2
  • Cited by: 0
  • Cites: 1
  • Additional Info: Cited Works Full text
Abstract

The present invention is directed to methods and formulations for treating, modifying, and/or managing gastrointestinal secretion, and intestinal conditions that cause the same. Methods of using at least one a3 ß4 nAChR antagonist and formulations comprising at least one a3 ß4 nAChR antagonist, or pharmaceutically acceptable salt thereof, are included.


Claims
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jul 31, 2008
  • Application: Jan 11, 2008
    WO IB 2008000905 W
  • Priority: Jan 26, 2007
    US US 69813107 A

Download Citation


Sign in to the Lens

Feedback